APA (7th ed.) Citation

HC, H., N, G., ZR, H., SL, W., XD, L., & JR, P. (2026). HSPA5 overexpression predicts poor prognosis and drives radioresistance and metastasis in nasopharyngeal carcinoma. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 283(6), 3963. https://doi.org/10.1007/s00405-026-10128-9

Chicago Style (17th ed.) Citation

HC, He, Ge N, Huang ZR, Wang SL, Lin XD, and Pan JR. "HSPA5 Overexpression Predicts Poor Prognosis and Drives Radioresistance and Metastasis in Nasopharyngeal Carcinoma." European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 283, no. 6 (2026): 3963. https://doi.org/10.1007/s00405-026-10128-9.

MLA (9th ed.) Citation

HC, He, et al. "HSPA5 Overexpression Predicts Poor Prognosis and Drives Radioresistance and Metastasis in Nasopharyngeal Carcinoma." European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, vol. 283, no. 6, 2026, p. 3963, https://doi.org/10.1007/s00405-026-10128-9.